Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20220517054898N1Phase 2Completed
Phase 2 trial of ibuprofen in irreversible pulpitis and odontalgia (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Postoperative pain intensity. Started Aug 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20220517054898N1.